Corpus ID: 46301760

Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys.

@article{EdsonHeredia2015DiseaseBA,
  title={Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys.},
  author={Emily Edson-Heredia and Baojin Zhu and JiaYing Guo and Tomoko Maeda‐Chubachi and Mark G. Lebwohl},
  journal={Cutis},
  year={2015},
  volume={95 3},
  pages={
          173-8
        }
}
The comorbidity profile and overall disease impact are not well understood in psoriasis with and without comorbid psoriatic arthritis (PsA). The objective of this study was to compare disease characteristics, comorbidities, and psoriasis-related quality of life (QOL) in patients with moderate to severe psoriasis with and without comorbid PsA using results from National Psoriasis Foundation (NPF) surveys. The study included 3395 and 2072 patients with psoriasis alone and psoriasis with PsA… Expand
Psoriasis and Co-morbidity.
TLDR
The relationships between Psoriasis and cardiovascular disease, psoriatic arthritis, mental health conditions, and immune-mediated diseases are discussed and are important to consider when developing the treatment plan and overall management of patients with psoriasis. Expand
Systemic Therapies in Psoriasis
TLDR
For patients with moderate-to-severe psoriasis, conventional systemic therapies can offer an effective, cost-effective, well-tolerated alternative treatment to topical treatments, light therapy, as well as the full spectrum of biologic agents. Expand
Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey
TLDR
Both skin and joint symptoms had a broad, meaningful impact on patient QoL, work productivity, daily activities, and emotional well-being, and joint severity and impact of joint symptoms were the strongest predictors of WPAI. Expand
Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab
TLDR
Improvements in PASI scores were directly moderately related to improvements in DLQI domain scores from initiation of treatment and extended over time, regardless of presence of comorbid PsA or treatment received. Expand
Incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate‐to‐severe psoriasis in five European countries
TLDR
Moderate‐to‐severe psoriasis is associated with reduced health‐related quality of life (HRQoL) among European adults, and data have generally been limited to clinical samples. Expand
Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis
TLDR
Musculoskeletal manifestations and comorbidities exert a deleterious effect in HRQoL of PsA patients, and optimal management of this condition needs to also address these manifestations in order to try to restore the QOL of these patients. Expand
The Impact of Psoriasis on the Quality of Life of Patients in San Antonio, TX
TLDR
Acutely, psoriasis patients are impacted psychologically and are frustrated with their disease, but over time, they learn to live with their condition and are impacted by the economic aspects of care. Expand
Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA
TLDR
PsA patients had a significantly higher PsA-related comorbidity burden, healthcare utilization, and direct healthcare costs than people free of PsA and PsO, underscoring the need for more effective treatments and improved care delivery systems. Expand
The psychosocial burden of psoriatic arthritis.
TLDR
How health-related quality of life (QoL) is affected in patients with PsA is described and measures used to evaluate the psychosocial impact of PsA are discussed, as well as strategies for evaluating the burdens associated with psoriatic arthritis and the results of properly managing patients withPsA. Expand
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry
There are a limited number of studies comparing psoriasis patients without psoriatic arthritis (PsA) to those with arthritis. Previous results are controversial.
...
1
2
...

References

SHOWING 1-10 OF 15 REFERENCES
Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
TLDR
Patients with PsA have a poorer QoL compared with those with PsC as measured by all questionnaires except the DLQI, which revealed a lowerQoL in patients with Ps C. Expand
The Burden of Moderate to Severe Psoriasis
TLDR
A comprehensive review of the evidence available concerning the social burden and costs of psoriasis found direct costs were higher than indirect costs, with hospitalization representing the most significant item and treatment costs showed wide variations between different studies. Expand
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
TLDR
Data from this study show that the more severe plaque psoriasis, the higher the direct and indirect costs for its management, and the relatively high average annual costs per patient point to the need for a more efficient and long-term control of Psoriasis. Expand
Determinants of quality of life in patients with psoriasis: a study from the US population.
TLDR
Patients with more extensive skin involvement have greater reductions in quality of life and female patients and young patients are affected to a greater extent. Expand
Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need.
TLDR
Patients with psoriasis represent a unique opportunity to identify individuals at very high risk of developing a chronic inflammatory arthropathy and by early identification of these patients, knowledge about PsA risk factors is especially important. Expand
Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
TLDR
Nontreatment and undertreatment of patients with psoriasis and psoriatic arthritis remain a significant problem in the United States and efforts in advocacy and education are necessary to ensure that effective treatments are accessible to this patient population. Expand
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
TLDR
It is important to note that patients included in recent drug trials resemble patients followed prospectively in a clinic, and patients with PsA who present with polyarticular disease are at risk for disease progression. Expand
Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011
TLDR
Patients with psoriasis and psoriatic arthritis continue to experience significant impairment of quality of life and work productivity. Expand
Update on the natural history and systemic treatment of psoriasis.
TLDR
It is hoped that further insight into the immunopathogenesis of psoriasis will provide the basis for the development of safer, more efficacious, and more durable therapeutics in the future. Expand
Epidemiology of psoriatic arthritis in the population of the United States.
TLDR
The prevalence of psoriatic arthritis among patients with psoriasis was 11% (95% CI: 9%, 14%) and varied substantially based on self-reporting of the extent of skin involvement with Psoriasis, which demonstrates the importance of performing broadly representative studies to measure the prevalence. Expand
...
1
2
...